Isomorphic Labs and MSD Announce AI-Driven Oncology Drug Discovery Partnership
Isomorphic Labs announced on November 19, 2026 a strategic research collaboration with MSD to discover small-molecule oncology drug candidates, combining its AI drug-design engine with selected proprietary targets.
Read the full story at Unite.AI ↗
Timeline · 1 report
- 2026-11-19 12:01 · Unite.AI
Isomorphic Labs and MSD Partner on AI Oncology Drug Discovery